Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. - Wikidata - awgldk - TriplyDB

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

http://www.wikidata.org/entity/Q53350997

about

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies Medicinal and injection therapies for mechanical neck disorders Botulinum toxin for subacute/chronic neck pain Botulinum toxin for subacute/chronic neck pain Medicinal and injection therapies for mechanical neck disorders Medicinal and Injection therapies for mechanical neck disorders Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs Development of macromolecular prodrug for rheumatoid arthritis NSAIDs: gastroprotection or selective COX-2 inhibitor?Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers Cyclooxygenase inhibition: between the devil and the deep blue sea The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study The cyclooxygenase-2 inhibitors: safety and effectiveness.Cyclo-oxygenase isoenzymes: physiological and pharmacological role.Aspirin and other anti-inflammatory drugs.Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.Cost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety.Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease.Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors.Economic evaluation of osteoarthritis treatment in Europe.Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population.Ameliorative effect of ocimum sanctum on meloxicam induced toxicity in wistar rats.An appraisal of innovative meloxicam mucoadhesive films for periodontal postsurgical pain control: A double-blinded, randomized clinical trial of effectiveness.Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.Meloxicam in rheumatoid arthritis.Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality.Review of the cardiovascular safety of COXIBs compared to NSAIDS.NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Is the large simple trial design used for comparative, post-approval safety research? A review of a clinical trials registry and the published literature.Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam.Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?Use of a once-daily NSAID in treatment of cyclic vomiting syndrome.Celecoxib and ankylosing spondylitis.COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials.Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial.Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.

P2860

Q21144617-50C0A073-9B37-433D-A830-196D6C245E74 Q24188098-7BBE3292-18DA-4828-A990-644E25B802EA Q24188110-2E20B766-8BD4-4D3F-9396-F06CEA40E1B7 Q24235339-97E4AA57-B1C9-4EAB-A3C5-1A7EBD98D3A7 Q24243952-FEDF496F-61E5-4F49-B91A-02D1E88DD3DB Q24247212-D1E3304B-5732-4B64-89F6-CB9B7F378983 Q24646764-3D4B47FF-4A0E-41F3-95E0-7DBDD00AFB29 Q24792554-58E1F26F-E655-47F3-B086-061D61F31B83 Q27693332-EA27423A-D94D-4FF1-A2AD-BC61B49C6CD2 Q28168965-62B0DA6E-059A-426A-BCEF-8F9B02D87FFA Q28168971-BF6C5841-34FD-4643-BEDA-C26BA63E1807 Q28192790-F0598CF3-33FD-450E-BB76-F6FCB0EFE386 Q33333061-556C12D0-5756-4A8B-91F4-ECE257DFB5A0 Q33735395-9CE94C3E-5E48-42E7-8863-4F0BD0EA8513 Q33904336-2FA9DA61-F088-45FF-B2A9-0B0B534937DB Q34036177-3FBE8B2C-5F6E-4308-B828-D2FD86B261D7 Q34095700-4B15A275-B8E8-453F-ABEA-60D24D499112 Q34384075-3F021228-C517-4A68-848A-EE406A658105 Q34561392-5A7C0F33-B6C4-4CA9-B618-A3C57FA0F0C6 Q34745694-F750F2C3-EB2F-4FC3-9A30-CC1EAF5383EA Q35058190-B3E2B228-8D70-4C74-A412-F79AFE9B85BA Q35076579-18D96984-B444-4321-8EA8-5D2D4FAC521A Q35196870-2E162CEF-381C-49D2-856B-86F13BABB89B Q35245147-ACD12583-47BF-49C9-B34D-19E415FF7F1B Q35997104-AC2F5BBD-F116-43B0-AEE8-81D44D609710 Q36195392-9D9F2D97-0047-45B7-9544-F3831133F24D Q36544898-CDBEE98C-8D48-4B9F-AC0E-F8F1B1C79492 Q37016976-2BFFEC2B-D0F7-4D3D-97A2-2D93C11E72E5 Q37178937-0753876B-9076-46B3-B67F-CC55375E9252 Q37409122-006EF9EA-5F8B-47F9-975B-B7F0207E0399 Q37893966-8C0FD2AA-6DA1-42A3-A691-AC23F57ABD10 Q37924275-11F0A1A1-F797-49E2-A754-5EA60B2096F2 Q41611791-FD362400-7EDD-4838-8563-131CE28F5CCA Q41879144-DCF3847A-3A0C-4F68-905D-83A673FD581D Q41969465-08C0E901-B85C-43DF-9E7B-08914557D954 Q43061712-3733416F-80EE-4FA5-821B-38866CF38ACE Q43086302-38CF7EB9-D93A-41E4-BA8A-B19F71CF5628 Q43742716-EB099C9F-CD21-4A6A-95F7-DA7F230F6EDC Q44089725-F92F0949-1046-41F6-B65D-C768F901FDA9 Q44293697-77884CAD-8FC1-4695-8609-975BD06DD5FE

P2860

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

http://www.wikidata.org/entity/Q53350997

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@en

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@nl

type

label

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@en

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@nl

prefLabel

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@en

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@nl

P1433

Q53350997-6E6587D3-535D-4C39-B751-133EEE5279CD

P1476

Q53350997-4171CE45-0231-4264-82AA-4726229943FC

P2093

Q53350997-094D0F0F-2086-4567-B86B-726FA86766F0

Q53350997-14D885D8-70AC-4DEF-9E4B-599E3B712606

Q53350997-5B79E4E2-9FD5-4191-ABEC-E2830F06962E

Q53350997-75FE32A8-B55B-49BB-91D4-E65698819ABC

Q53350997-80AE59C8-A77D-4BAD-A8DE-020E47EF03BD

Q53350997-A9F94EE1-E18C-42DC-A647-3E58F06CFBBC

Q53350997-ACA73267-1E1D-4E8C-A5ED-385EDEFC03C6

Q53350997-CA548DE0-86EE-42D9-81D3-0F2871B35F3E

Q53350997-E5494FF1-AF69-45D1-BAD5-340220A63A5B

Q53350997-E57A13D6-FACB-49AF-9A0E-F82AEB324E46

P304

Q53350997-CB30BBA9-0854-48CB-AB01-7917B4F58124

P31

Q53350997-D3E199CA-1F23-42BF-A384-8D0594955ADB

P356

Q53350997-ACEA3460-A05A-452F-9842-7BF787257F1D

P433

Q53350997-3FF9E651-9099-4E2C-BBFD-933AFE912C93

P478

Q53350997-6211C524-8940-454A-934C-B847123B4A70

P577

Q53350997-8BCFA80B-B760-4679-9D5B-BEC2014C00BA

P5875

Q53350997-5AD95BEB-8ACA-41AE-B392-E3F965ABA47B

P698

Q53350997-F0273233-5820-4EC8-9640-A58ABC45895C

P921

Q53350997-194831BD-296B-43F1-860B-E81B05A9AB6C

Q53350997-7857A6DC-29DB-4896-B0DD-5001D07E20F4

Q53350997-938AD3C2-21AE-4823-A91D-D9303C02D41D

P356

P1433

British Journal of Rheumatology

P1476

Gastrointestinal tolerability ...... ional Study Safety Assessment.

@en

P2093

A Kahan

http://www.w3.org/2001/XMLSchema#string

B Bégaud

http://www.w3.org/2001/XMLSchema#string

C Alegre

http://www.w3.org/2001/XMLSchema#string

C Hawkey

http://www.w3.org/2001/XMLSchema#string

E Baumelou

http://www.w3.org/2001/XMLSchema#string

G Littlejohn

http://www.w3.org/2001/XMLSchema#string

H Isomäki

http://www.w3.org/2001/XMLSchema#string

J Dequeker

http://www.w3.org/2001/XMLSchema#string

J Mau

http://www.w3.org/2001/XMLSchema#string

K Steinbrück

http://www.w3.org/2001/XMLSchema#string

P304

937-945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/37.9.937

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

1998-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13502114

http://www.w3.org/2001/XMLSchema#string

P698

9783757

http://www.w3.org/2001/XMLSchema#string

P921